Combinaison thérapeutique contenant des aminotetrahydropyrannes en tant qu'inhibiteurs de dipeptidyl peptidase-IV pour le traitement ou la prévention des diabètes
The present invention is directed to a combination comprising a compound of structural formula I or a pharmaceutically acceptable salt thereof and one or more other drugs; wherein the variables are as defined in the specification.Compouds (I) are inhibtors of the enzyme dipeptidyl peptidase IV (dpp4-inhibitors) and may be used in the reatment of diabetes.